Abingdon Health Ltd. announced the appointment of Dr. David Pritchard as Chief Technology Officer. David has a track record of success within the medical diagnostics industry having spent the last twenty years at Axis-Shield Diagnostics, most recently as Head of Research. At Axis-Shield David was responsible for a Research and Development (R&D) team of 50 staff involved in the identification, evaluation, development and commercialisation of novel and challenging immunoassays. David is a member of the Industrial Advisory Group of the Institute of Bio-Sensing Technology. David will be responsible for the Group’s lateral flow immunoassay and reader development programmes based at the Group’s Birmingham site including the management of the Group’s development of the next generation lateral flow biosensor system in partnership with Sumitomo Chemical Corporation. David will be a member of the Group’s Executive Team and will report into Chris Yates, CEO. Dene Baldwin, current Technical Director, has decided to retire but will continue to work with Abingdon Health going forward in a consultancy capacity.